170 related articles for article (PubMed ID: 17620751)
21. [Health care to HIV/AIDS patients in Brazil].
Portela MC; Lotrowska M
Rev Saude Publica; 2006 Apr; 40 Suppl():70-9. PubMed ID: 16729161
[TBL] [Abstract][Full Text] [Related]
22. Implementation and Operational Research: Effect of Universal Access to Antiretroviral Therapy on HIV/AIDS Mortality in Mexico 1990-2011.
Hernández-Ávila JE; Palacio-Mejía LS; Hernández-Romieu A; Bautista-Arredondo S; Sepúlveda Amor J; Hernández-Ávila M
J Acquir Immune Defic Syndr; 2015 Jul; 69(3):e100-8. PubMed ID: 25886921
[TBL] [Abstract][Full Text] [Related]
23. Driving a decade of change: HIV/AIDS, patents and access to medicines for all.
Hoen E'; Berger J; Calmy A; Moon S
J Int AIDS Soc; 2011 Mar; 14():15. PubMed ID: 21439089
[TBL] [Abstract][Full Text] [Related]
24. Initiatives to challenge patent barriers and their relationship with the price of medicines procured by the Brazilian Unified National Health System.
Scopel CT; Chaves GC
Cad Saude Publica; 2016 Dec; 32(11):e00113815. PubMed ID: 27925025
[TBL] [Abstract][Full Text] [Related]
25. The economics of effective AIDS treatment in Thailand.
Over M; Revenga A; Masaki E; Peerapatanapokin W; Gold J; Tangcharoensathien V; Thanprasertsuk S
AIDS; 2007 Jul; 21 Suppl 4():S105-16. PubMed ID: 17620745
[TBL] [Abstract][Full Text] [Related]
26. The Brazilian experiment: HIV drugs for all.
Flaer PJ; Younis MZ
J Health Care Finance; 2009; 36(2):90-6. PubMed ID: 20499725
[TBL] [Abstract][Full Text] [Related]
27. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.
Cohen J
Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654
[No Abstract] [Full Text] [Related]
28. AIDS at Christmas time.
Nature; 2005 Dec; 438(7071):1051. PubMed ID: 16371960
[No Abstract] [Full Text] [Related]
29. "We all have AIDS": case for reducing the cost of HIV drugs to zero.
Berwick D
BMJ; 2002 Jan; 324(7331):214-6. PubMed ID: 11809645
[No Abstract] [Full Text] [Related]
30. In the high court of South Africa, case no. 4138/98: the global politics of access to low-cost AIDS drugs in poor countries.
Barnard D
Kennedy Inst Ethics J; 2002 Jun; 12(2):159-74. PubMed ID: 12476916
[TBL] [Abstract][Full Text] [Related]
31. Antiretroviral manufacturers and the challenge of universal access to drugs through the Brazilian National STD/AIDS Program.
do Lago RF; Costa Ndo R
Cad Saude Publica; 2009 Oct; 25(10):2273-84. PubMed ID: 19851626
[TBL] [Abstract][Full Text] [Related]
32. [AIDS: the world's future is in 'their' hands, but comes from 'our' pockets; an impression from the World AIDS Conference in South Africa].
Veeken H
Ned Tijdschr Geneeskd; 2000 Dec; 144(49):2363-7. PubMed ID: 11129973
[TBL] [Abstract][Full Text] [Related]
33. Improvement of HAART in Brazil, 1998-2008: a nationwide assessment of survival times after AIDS diagnosis among men who have sex with men.
Malta M; da Silva CM; Magnanini MM; Wirtz AL; Perissé AR; Beyrer C; Strathdee SA; Bastos FI
BMC Public Health; 2015 Mar; 15():226. PubMed ID: 25886530
[TBL] [Abstract][Full Text] [Related]
34. The AIDS response catalysing economic and social transformation: the importance of local pharmaceutical production.
Sidibé M
Antivir Ther; 2014; 19 Suppl 3():3-4. PubMed ID: 25310132
[No Abstract] [Full Text] [Related]
35. Economic returns to investment in AIDS treatment in low and middle income countries.
Resch S; Korenromp E; Stover J; Blakley M; Krubiner C; Thorien K; Hecht R; Atun R
PLoS One; 2011; 6(10):e25310. PubMed ID: 21998648
[TBL] [Abstract][Full Text] [Related]
36. Dispatches from the front line.
Nature; 2002 Aug; 418(6897):465. PubMed ID: 12152038
[No Abstract] [Full Text] [Related]
37. Prioritising access to antiretroviral therapy in resource-poor settings.
Lange JM; van der Waals FW
J HIV Ther; 2002 Aug; 7(3):59-62. PubMed ID: 12442166
[TBL] [Abstract][Full Text] [Related]
38. Highly active antiretroviral therapy in Brazil: the challenge of universal access in a context of social inequality.
Hacker MA; Petersen ML; Enriquez M; Bastos FI
Rev Panam Salud Publica; 2004 Aug; 16(2):78-83. PubMed ID: 15357932
[TBL] [Abstract][Full Text] [Related]
39. UN political declaration on HIV and AIDS: where to begin?
Poku NK
Lancet; 2016 Aug; 388(10046):743-4. PubMed ID: 27560262
[No Abstract] [Full Text] [Related]
40. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.
Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B
AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
